|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||2.2100 - 2.2550|
|52 Week Range||1.5846 - 2.7491|
|Beta (5Y Monthly)||0.45|
|PE Ratio (TTM)||8.17|
|Forward Dividend & Yield||0.54 (24.92%)|
|Ex-Dividend Date||Jun. 01, 2021|
|1y Target Est||N/A|
Philip Morris (PM) secures more than 74% of Vectura's shares to become a majority stakeholder. The company expects to amplify growth in its Beyond Nicotine strategy via this move.
British inhaler developer Vectura has been barred from a major medical conference amid a growing backlash over its £1bn takeover by tobacco giant Philip Morris International.